achievement rate and predictive factors of clinical remission in patients with severe asthma under biologics treatment

achievement rate and predictive factors of clinical remission in patients with severe asthma under biologics treatment - clinical remission in patients with severe asthma under biologics

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054896

Enrollment

Registered

2024-07-06

Start date

2024-07-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) adult patients equal or more than 20 years (2) patients who had been diagnosed as asthma or cough variant asthma from August 1 2013 to April 30 2024 (3) patients who had undergone biologics treatment for asthma or cough variant asthma

Exclusion criteria

Exclusion criteria: patients who reject to enrollment of study

Design outcomes

Primary

Measure	Time frame
achievement rate of clinical remission in patients with severe asthma one year after administration of biologics	—

Secondary

Measure	Time frame
(1) difference in clinical characteristics and disease phenotype in between patients with achievement of clinical remission and those without (2) difference in clinical remission among biologics (3) achievement rate of clinical remission in patients with severe asthma two years after administration of biologics	—

Countries

Japan

Contacts

Public ContactTomoko Tajiri

Graduate School of Medical Sciences, Nagoya City University Department of Respiratory Medicine, Allergy and Clinical Immunology

tomokot@med.nagoya-cu.ac.jp0528538216

Outcome results